Drug Shortage Report for LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION USP

Last updated on 2021-05-15 History
Report ID 139438
Drug Identification Number 02436221
Brand name LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION USP
Common or Proper name LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE
Company Name HIKMA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) EPINEPHRINE LIDOCAINE HYDROCHLORIDE
Strength(s) 0.01MG 20MG
Dosage form(s) SOLUTION
Route of administration BLOCK/INFILTRATION BLOCK/INFILTRATION
Packaging size 50 mL
ATC code N01BB
ATC description ANESTHETICS, LOCAL
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2021-05-14
Actual start date
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2021-05-15
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 5995 AVEBURY ROAD, SUITE 804
MISSISSAUGA, ONTARIO
CANADA L5R 3P9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2021-05-15 English Compare
v3 2021-05-14 French Compare
v2 2021-05-14 English Compare
v1 2021-05-14 English Compare

Showing 1 to 4 of 4